Mangoceuticals, Inc.（纳斯达克代码：MGRX）今日正式宣布，已与Nuclea Energy Inc.签署商业合并协议。此举旨在加速推进下一代核微反应器技术的发展与应用。这一战略合作，无疑将为清洁能源领域注入一股强劲的革新动力。通过整合双方优势资源，共同致力于打造更高效、更安全的核能解决方案，以应对日益增长的可持续能源需求。此次合并，标志着Mangoceuticals向能源技术领域迈出了关键一步。
Mangoceuticals, Inc.（纳斯达克代码：MGRX）今日正式宣布，已与Nuclea Energy Inc.签署商业合并协议。此举旨在加速推进下一代核微反应器技术的发展与应用。这一战略合作，无疑将为清洁能源领域注入一股强劲的革新动力。通过整合双方优势资源，共同致力于打造更高效、更安全的核能解决方案，以应对日益增长的可持续能源需求。此次合并，标志着Mangoceuticals向能源技术领域迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.